Kurt Schultz

PGY-Lab @YaleSurgery. PhD candidate @YaleGSAS. Social epidemiology ↔️ health psychology ↔️ causal inference. Previously @UMassChan @BostonSOAR @UMassCHC

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

We're thrilled to officially announce the 2026 class of Conquer Cancer Grants and Awards recipients! 🔬 These grants empower the next generation of physician-scientists to turn innovative ideas into clinical breakthroughs. Congratulations to the new class—see you in Chicago for #ASCO26!

Full list of recipients here: https://t.co/Ltov9bTGYi

#ResearchConquersCancer #ConquerCancer @ASCO

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

Live from #ASCO26: We’ve officially welcomed the Conquer Cancer Grants and Awards Class of 2026! 🏆 This funding empowers early-career researchers to accelerate the breakthroughs patients need most. Congratulations to this year’s recipients for their dedication to conquering cancer.

Read the full announcement: https://t.co/Ltov9bTGYi

#ResearchConquersCancer #CancerResearch @ASCO

[Elliott R Haut, MD, PhD, MAMSE @elliotthaut]

Could not be more proud of Dr. Lisa Kodadek, one my past @HopkinsMedicine @hopkinssurgery surgical trainees and mentees. @LisaKodadek on behalf of the @traumadoctors critical care committee. @JoeC_TraumaDoc @SteinSister

[Trauma Surgery & Acute Care Open (TSACO) @TSACO_AAST]

Trauma surgeons know the sickest patients don’t stop at one complication.

This TSACO paper on postinjury multiple organ failure helped redefine how we think about inflammation, critical illness, and the downstream consequences of severe trauma. This is years after “damage control” first entered the lexicon.

For TSACO’s 10-year anniversary, hear directly from Dr. Lisa Kodadek.

Read here https://t.co/pmh5Z8OlKj

Authors: @LisaKodadek, @scarmic8, @anu_seshadri, @AppelbaumMD

[Jennifer F Tseng MD MPH @TsengJennifer]

“Yes, you’ll feel like you’re the worst ever when you come back to clinical from research years … and then you’ll help patients … and then it will be OK.”

🙌 👏 all those who take time for 🔬 🧬 including @kiyahandersonmd @Khuatyy @BUMedicine @BMCSurgery !

[Annals of Surgical Oncology @AnnSurgOncol]

Featured: Repeat #CytoreductiveSurgery for #ColorectalCancer Metastatic to the #Peritoneal Cavity

https://t.co/qjmDaqbdg1

@SchultzKurt
@SyedAAhmad5
@SocSurgOnc

[Yale University @Yale]

The envelopes are open.

At @YaleMed, the M.D. Class of 2026 just learned where they’ll begin the next chapter of their journeys in medicine.

Inside Harkness Hall, students shared the moment with classmates, families, faculty, and mentors who have been part of the path to this day.

➡️ ➡️ ➡️ Swipe to see where they’re headed next.

[Yale Cancer Center @YaleCancer]

Congratulations to Drs. @BillingsleyMd, @sajkhanmd, @pathik_aravind, and the entire surgical team involved in the first #RoboticHepaticArterialPump placement at Yale and in the state of #Connecticut. A tremendous accomplishment!
https://t.co/FT87rE919a
@SmilowCancer @YaleGICancers @YNHH

[Assoc4AcademicSurgery @AcademicSurgery]

We are pleased to announce the winner of the Ethics Committee’s Annual Essay Challenge for the 2026 Essay Festival, which featured the theme “Living Your Values.”

Please join us in congratulating Dr. Christopher Noda and co-author Dr. Katie Rowland!

Read their award-winning essay, “I Am Here to Spend Time with You,” https://t.co/6MswQPkiD0

[Yale Cancer Center @YaleCancer]

.@princygupta19 shows how mass-based response testing (MRT) can guide treatment decisions in peritoneal metastases by identifying patients likely to resist therapy. Tumors flagged as resistant by MRT were strongly linked to progression. #SSO2026 @SmilowCancer @SocSurgOnc @OncoAlert @kturaga @YaleGICancers

[Yale Cancer Center @YaleCancer]

.@kturaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, and doing what’s right for our patients. This consensus platform will help move the field forward.” #SSO2026 @SocSurgOnc @SmilowCancer @YaleMed

[Yale Cancer Center @YaleCancer]

.@kturaga joined the @SocSurgOnc podcast #SurgOncToday to discuss the newly endorsed guidelines from the Yale Peritoneal Surface Malignancy Consortium. #PSM
https://t.co/C6LjPI9NeH
@SmilowCancer @YaleGICancers

[Yale Cancer Center @YaleCancer]

Congratulations to John Kunstman, MD, MHS, recipient of the @YaleCancer Clinical Excellence Award by @kturaga. Dr. Kunstman is a surgical oncologist specializing in the care of patients with cancers or benign diseases of the pancreas, liver, bile ducts, stomach, and intestines.
@SmilowCancer @YaleSurgery

[Yale Cancer Center @YaleCancer]

New research from @YaleGICancers led by @princygupta19 @kturaga on early-onset appendiceal cancer shows ⬆️ rates of PIK3CA mutations which are associated with worse survival. Findings point to new opportunities for molecular risk stratification and targeted therapy.
https://t.co/iWJeuaPx9h @JCOPO_ASCO @JSheltzer @sundar__raghav @Cecchini_OncMD @ElizLGodfreyMD @SchultzKurt @sbutensky @ArdamanShergil1

[Yale Nephrology @YaleNephrology]

Congratulations to "Dr." Dr. Megan Baker (@meganlebaker) on successfully defending her PhD through the Investigative Medicine Program yesterday! 🎉🎓

So proud of this accomplishment - Yale Nephrology showed up in full force to fill Fitkin Auditorium and cheer her on! 🥂

[Yale Internal Medicine @YaleIMed]

The Office of Health Equity Research announced the recipients and finalists of the '25 OHER Awards for Yale Research Excellence, which recognizes outstanding contributions to research aimed at improving health equity & addressing health disparities.

Read➡️https://t.co/paU5GFG1MI

[Kurt Schultz @SchultzKurt]

Important work by @AlissaGreenbaum et al. on caregiver burden, regret, QoL in #AppendicealCancer #CRSHIPEC.

Grateful to @acpmpresearch patients who make this work possible. Complementary efforts by @ElizLGodfreyMD @GreenupRachel @kturaga. Stay tuned! https://t.co/amerWnal6K

[Annals of Surgical Oncology @AnnSurgOncol]

February Issue: Decision Regret and Burden in Caregivers of Patients with #AppendicealCancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) @AlissaGreenbaum

https://t.co/3MU3UuUeMs

@SchultzKurt
@SyedAAhmad5
@SocSurgOnc

[Annals of Surgical Oncology @AnnSurgOncol]

February Issue: Decision Regret and Burden in Caregivers of Patients with #AppendicealCancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) @AlissaGreenbaum

https://t.co/3MU3UuUeMs

@SchultzKurt
@SyedAAhmad5
@SocSurgOnc

[Julie Hallet @HalletJulie]

Methods corner: multivariable adjustment ≠ causal effects

Do you know about Table 2 fallacy?
🤔Misinterprets adjusted covariates as causal effects
📊1 of 5 studies in high-impact surgery journals
⚠️Risk of distorted clinical inference

Learn more https://t.co/7wDaQF70lK

[Yale Cancer Center @YaleCancer]

New research from @kturaga @YaleGICancers shows how in #colorectalcancer with peritoneal metastases, CMS4 tumors have unique drug sensitivities, highlighting the need for subtype-guided personalized #HIPEC strategies.
https://t.co/OHml9Ho07O
@SmilowCancer @AnnSurgOncol @princygupta19 @JSheltzer @sundar__raghav @Cecchini_OncMD @ElizLGodfreyMD @SchultzKurt